BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 16835077)

  • 1. Climacteric symptoms and hormones.
    Schindler AE
    Gynecol Endocrinol; 2006 Mar; 22(3):151-4. PubMed ID: 16835077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychosocial aspects of the climacteric].
    Buddeberg C; Buddeberg-Fischer B
    Praxis (Bern 1994); 1995 Jun; 84(24):718-21. PubMed ID: 7792468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Options for hormone therapy in women who have had a hysterectomy.
    Haney AF; Wild RA
    Menopause; 2007; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of climacteric symptoms (Menopause Rating Scale)].
    Hauser GA; Huber IC; Keller PJ; Lauritzen C; Schneider HP
    Zentralbl Gynakol; 1994; 116(1):16-23. PubMed ID: 8147175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone, progestogens and psychosomatic health of the climacteric woman.
    Bitzer J
    Maturitas; 2009 Apr; 62(4):330-3. PubMed ID: 19091497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of symptoms in relation to androgen concentrations in women using estrogen plus progestogen and women using estrogen alone.
    Spetz AC; Fredriksson MG; Lidfeldt J; Samsioe GN
    Menopause; 2009; 16(1):149-55. PubMed ID: 18779755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexuality during the climacteric period.
    da Silva Lara LA; Useche B; Rosa E Silva JC; Ferriani RA; Reis RM; de Sá MF; de Carvalho BR; Carvalho MA; de Sá Rosa E Silva AC
    Maturitas; 2009 Feb; 62(2):127-33. PubMed ID: 19186014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of hormone replacement therapy for climacteric symptoms.
    Takeo C; Ugai K; Araki J; Zhang L; Baba M; Ohashi W; Ueno K; Suzuki Y; Amano K; Hirai A; Muramatsu M
    Biochem Biophys Res Commun; 2008 Oct; 374(4):604-8. PubMed ID: 18627768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and health protection.
    Chiechi LM
    Curr Opin Investig Drugs; 2003 Apr; 4(4):439-43. PubMed ID: 12808884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychosomatic aspects of menopause: review of the literature 1988-1992].
    von Sydow K; Reimer C
    Psychother Psychosom Med Psychol; 1995 Jul; 45(7):225-36. PubMed ID: 7676004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing women's quality of life in the later half of life.
    Chiu YW; Moore RW; Hsu CE; Huang CT; Liu HW; Chuang HY
    Climacteric; 2008 Jun; 11(3):201-11. PubMed ID: 18568785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peroral treatment with natural human estrogens in the climacteric].
    Sele V; Obel E
    Ugeskr Laeger; 1980 Sep; 142(38):2497-500. PubMed ID: 7445154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Official position of the Chilean Society of Climacteric on the management of climacteric women].
    Blümel JE; Aravena H; Brantes S; Cruzat L; Lavín P; Montaño R; Navarrete I; Osorio E
    Rev Med Chil; 2010 May; 138(5):645-51. PubMed ID: 20668822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current trends in hormone replacement therapy: perceptions and usage.
    Birkhäuser MH; Reinecke I
    Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
    Diaby V; Perreault S; Lachaine J
    Maturitas; 2007 Oct; 58(2):138-49. PubMed ID: 17870259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
    Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
    J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and alternative therapy of the menopausal patient.
    Lichten EM
    Prim Care; 1978 Dec; 5(4):607-14. PubMed ID: 253359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
    Pitkin J; Smetnik VP; Vadász P; Mustonen M; Salminen K; Ylikangas S;
    Menopause Int; 2007 Sep; 13(3):116-23. PubMed ID: 17785037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.